- Home
- SSBI vs IKNA Comparison
SSBI vs IKNA Comparison
Compare SSBI & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSBI
- IKNA
- Stock Information
- Founded
- SSBI 1982
- IKNA 2016
- Country
- SSBI United States
- IKNA United States
- Employees
- SSBI N/A
- IKNA N/A
- Industry
- SSBI Major Banks
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- SSBI Finance
- IKNA Health Care
- Exchange
- SSBI Nasdaq
- IKNA Nasdaq
- Market Cap
- SSBI 66.3M
- IKNA 61.8M
- IPO Year
- SSBI 2006
- IKNA 2021
- Fundamental
- Price
- SSBI $9.60
- IKNA $1.36
- Analyst Decision
- SSBI
- IKNA Strong Buy
- Analyst Count
- SSBI 0
- IKNA 1
- Target Price
- SSBI N/A
- IKNA $4.00
- AVG Volume (30 Days)
- SSBI 6.4K
- IKNA 95.6K
- Earning Date
- SSBI 07-30-2025
- IKNA 08-07-2025
- Dividend Yield
- SSBI 0.43%
- IKNA N/A
- EPS Growth
- SSBI N/A
- IKNA N/A
- EPS
- SSBI N/A
- IKNA N/A
- Revenue
- SSBI $25,932,000.00
- IKNA N/A
- Revenue This Year
- SSBI N/A
- IKNA N/A
- Revenue Next Year
- SSBI N/A
- IKNA N/A
- P/E Ratio
- SSBI N/A
- IKNA N/A
- Revenue Growth
- SSBI N/A
- IKNA N/A
- 52 Week Low
- SSBI $5.68
- IKNA $0.97
- 52 Week High
- SSBI $10.93
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- SSBI 48.22
- IKNA 56.43
- Support Level
- SSBI $9.76
- IKNA $1.10
- Resistance Level
- SSBI $9.97
- IKNA $1.46
- Average True Range (ATR)
- SSBI 0.12
- IKNA 0.07
- MACD
- SSBI -0.07
- IKNA -0.00
- Stochastic Oscillator
- SSBI 0.00
- IKNA 57.58
About SSBI Summit State Bank
Summit State Bank provides various banking products and services to individuals and businesses primarily in Sonoma County, California. It offers personal and business checking, money market, sweep, savings, and demand accounts; time certificates of deposit; and specialized deposit accounts, such as professional, small business packaged, tiered, and retirement plan accounts. The company also provides loans, including commercial loans and leases; lines of credit; commercial real estate, small business administration, residential mortgage, and construction loans; home equity lines of credit; and term and equipment loans, as well as loans to agriculture-related businesses.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.